Atlas Trials

Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma

Clinical trial NCT01816555 · TERMINATED

Trial details

NCT number
NCT01816555
Sponsor
Medical University of South Carolina
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
Start date
2013-01-01
Primary completion
2014-11-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.